Biocon has informed that the Board of Directors of the Company at its meeting held on April 25, 2013 has recommended a final dividend of Rs. 5 per share (i.e. 100%) and a special dividend of Rs. 2.50 per share (i.e.50%) for the financial year 2012-13.
The declaration of dividend is subject to shareholders’ approval at the ensuing Annual General Meeting of the Company. Subsequent to Shareholders approval the dividend will be paid within a period of 30 days from the date of such approval.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.35 |
| Dr. Reddys Lab | 1236.85 |
| Cipla | 1232.80 |
| Zydus Lifesciences | 942.40 |
| Lupin | 2332.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: